Am. J. Respir. Cell Mol. Biol., Vol 14, No. 1, 01 1996, 27-35.
Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids
JH Wang, JL Devalia, C Xia, RJ Sapsford and RJ Davies
Department of Respiratory Medicine and Allergy, St. Bartholomew's Hospital, London, United Kingdom.
Recent studies have demonstrated that RANTES, a member of the CC chemokine
family affecting monocytes, T cells, basophils, and eosinophils, is
expressed by several cell types. To investigate whether human bronchial
epithelial cells can also express this chemokine, we investigated human
bronchial epithelial cells for their ability to synthesize RANTES, both in
vitro and in vivo. Additionally, we investigated the effect of treatment
for 4 mo with inhaled corticosteroids on the expression of RANTES in these
cells in vivo. Human bronchial epithelial cells cultured from surgical
tissue expressed the mRNA for RANTES and synthesized RANTES, as
demonstrated by polymerase chain reaction and immunocytochemical staining
and enzyme- linked immunosorbent assay, respectively. Incubation of the
cultures with 50 ng/ml of tumor necrosis factor-alpha (TNF-alpha)
significantly increased the release of RANTES into culture medium after 18
to 48 h of incubation, an effect that was abolished by treatment of the
cultures with anti-TNF-alpha antibody. RANTES was also expressed in the
bronchial epithelium in vivo, as indicated by positive immunocytochemical
staining of bronchial biopsy tissues obtained from mild asthmatic patients
before and after treatment with 500 micrograms of inhaled beclomethasone
dipropionate (BDP) twice daily or matched placebo for 4 mo. Quantitation,
by color image analysis, of the percentage of epithelium staining for
RANTES showed that treatment with BDP decreased the expression of RANTES in
the bronchial epithelium from 17.12% to 4.22% (P < 0.05). The numbers of
EG2-staining cells in the epithelium were also reduced, from 790.1/mm2 to
203.3/mm2 (geometric mean; P < 0.01), after BDP treatment. These results
suggest that human bronchial epithelial cells are capable of synthesizing
RANTES and may therefore play an important role in the development of
inflammation in allergic airways disease. Furthermore, corticosteroids may
prevent airway inflammation by downregulating the expression of
proinflammatory cytokines in the bronchial epithelium.
This article has been cited by other articles:

|
 |

|
 |
 
K. Nishina, F. Zhang, L. D. Nielsen, K. Edeen, J. Wang, and R. J. Mason
Expression of CINC-2{beta} Is Related to the State of Differentiation of Alveolar Epithelial Cells
Am. J. Respir. Cell Mol. Biol.,
November 1, 2005;
33(5):
505 - 512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Alikhani, Z. Alikhani, and D. T. Graves
FOXO1 Functions as a Master Switch That Regulates Gene Expression Necessary for Tumor Necrosis Factor-induced Fibroblast Apoptosis
J. Biol. Chem.,
April 1, 2005;
280(13):
12096 - 12102.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Quraishi, M. J. Davies, and T. J. Craig
Inflammatory Responses in Allergic Rhinitis: Traditional Approaches and Novel Treatment Strategies
J Am Osteopath Assoc,
May 1, 2004;
104(5_suppl):
7S - 15S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Page, J. Li, L. Zhou, S. Iasvoyskaia, K. C. Corbit, J.-W. Soh, I. B. Weinstein, A. R. Brasier, A. Lin, and M. B. Hershenson
Regulation of Airway Epithelial Cell NF-{kappa}B-Dependent Gene Expression by Protein Kinase C{delta}
J. Immunol.,
June 1, 2003;
170(11):
5681 - 5689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, S. Kartha, S. Iasvovskaia, A. Tan, R. K. Bhat, J. M. Manaligod, K. Page, A. R. Brasier, and M. B. Hershenson
Regulation of human airway epithelial cell IL-8 expression by MAP kinases
Am J Physiol Lung Cell Mol Physiol,
October 1, 2002;
283(4):
L690 - L699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Holtzman, J. D. Morton, L. P. Shornick, J. W. Tyner, M. P. O'Sullivan, A. Antao, M. Lo, M. Castro, and M. J. Walter
Immunity, Inflammation, and Remodeling in the Airway Epithelial Barrier: Epithelial-Viral-Allergic Paradigm
Physiol Rev,
January 1, 2002;
82(1):
19 - 46.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Sekine, K. Yasufuku, K. M. Heidler, O. W. Cummings, N. Van Rooijen, T. Fujisawa, J. Brown, and D. S. Wilkes
Monocyte Chemoattractant Protein-1 and RANTES Are Chemotactic for Graft Infiltrating Lymphocytes during Acute Lung Allograft Rejection
Am. J. Respir. Cell Mol. Biol.,
December 1, 2000;
23(6):
719 - 726.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. M A. El-Asrar, S. Struyf, S. A Al-Kharashi, L. Missotten, J. Van Damme, and K. Geboes
Chemokines in the limbal form of vernal keratoconjunctivitis
Br. J. Ophthalmol.,
December 1, 2000;
84(12):
1360 - 1366.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. BOUSQUET, P. K. JEFFERY, W. W. BUSSE, M. JOHNSON, and A. M. VIGNOLA
Asthma . From Bronchoconstriction to Airways Inflammation and Remodeling
Am. J. Respir. Crit. Care Med.,
May 1, 2000;
161(5):
1720 - 1745.
[Full Text]
|
 |
|

|
 |

|
 |
 
R. G. Nickel, V. Casolaro, U. Wahn, K. Beyer, K. C. Barnes, B. S. Plunkett, L. R. Freidhoff, C. Sengler, J. R. Plitt, R. P. Schleimer, et al.
Atopic Dermatitis Is Associated with a Functional Mutation in the Promoter of the C-C Chemokine RANTES
J. Immunol.,
February 1, 2000;
164(3):
1612 - 1616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. HART, S. LIM, I. ADCOCK, P. J. BARNES, and K. FAN CHUNG
Effects of Inhaled Corticosteroid Therapy on Expression and DNA-Binding Activity of Nuclear Factor kappa B in Asthma
Am. J. Respir. Crit. Care Med.,
January 1, 2000;
161(1):
224 - 231.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Hidi, V. Riches, M. Al-Ali, W. W. Cruikshank, D. M. Center, S. T. Holgate, and R. Djukanovic
Role of B7-CD28/CTLA-4 Costimulation and NF-{kappa}B in Allergen-Induced T Cell Chemotaxis by IL-16 and RANTES
J. Immunol.,
January 1, 2000;
164(1):
412 - 418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Stellato, S. Matsukura, A. Fal, J. White, L. A. Beck, D. Proud, and R. P. Schleimer
Differential Regulation of Epithelial-Derived C-C Chemokine Expression by IL-4 and the Glucocorticoid Budesonide
J. Immunol.,
November 15, 1999;
163(10):
5624 - 5632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Jedrzkiewicz, G. Kataeva, C. M. Hogaboam, S. L. Kunkel, R. M. Strieter, and D. M. McKay
Superantigen Immune Stimulation Evokes Epithelial Monocyte Chemoattractant Protein 1 and RANTES Production
Infect. Immun.,
November 1, 1999;
67(11):
6198 - 6202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R. MILLS, R. J. DAVIES, and J. L. DEVALIA
Airway Epithelial Cells, Cytokines, and Pollutants
Am. J. Respir. Crit. Care Med.,
November 1, 1999;
160(5):
S38 - 43.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Han, J. H. Kim, Y. J. Noh, H. S. Chang, C. S. Kim, K.-S. Kim, S. Y. Ki, C. S. Park, and I. Y. Chung
Interleukin (IL)-5 Downregulates Tumor Necrosis Factor (TNF)-Induced Eotaxin Messenger RNA (mRNA) Expression in Eosinophils . Induction of Eotaxin mRNA by TNF and IL-5 in Eosinophils
Am. J. Respir. Cell Mol. Biol.,
September 1, 1999;
21(3):
303 - 310.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. M. Schwiebert, K. Estell, and S. M. Propst
Chemokine expression in CF epithelia: implications for the role of CFTR in RANTES expression
Am J Physiol Cell Physiol,
March 1, 1999;
276(3):
C700 - C710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Profita, A. M. Vignola, A. Sala, A. Mirabella, L. Siena, E. Pace, G. Folco, and G. Bonsignore
Interleukin-4 Enhances 15-Lipoxygenase Activity and Incorporation of 15(S)-HETE into Cellular Phospholipids in Cultured Pulmonary Epithelial Cells
Am. J. Respir. Cell Mol. Biol.,
January 1, 1999;
20(1):
61 - 68.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. J. Barnes, K. F. Chung, and C. P. Page
Inflammatory Mediators of Asthma: An Update
Pharmacol. Rev.,
December 1, 1998;
50(4):
515 - 596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. HALEY, M. E. SUNDAY, B. R. WIGGS, H. P. KOZAKEWICH, J. J. REILLY, S. J. MENTZER, D. J. SUGARBAKER, C. M. DOERSCHUK, and J. M. DRAZEN
Inflammatory Cell Distribution within and along Asthmatic Airways
Am. J. Respir. Crit. Care Med.,
August 1, 1998;
158(2):
565 - 572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Taguchi, D. Sampath, T. Koga, M. Castro, D. C. Look, S. Nakajima, and M. J. Holtzman
Patterns for RANTES Secretion and Intercellular Adhesion Molecule 1 Expression Mediate Transepithelial T Cell Traffic Based on Analyses In Vitro and In Vivo
J. Exp. Med.,
June 15, 1998;
187(12):
1927 - 1940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. BAROODY, P. ROUADI, P. V. DRISCOLL, B. S. BOCHNER, and R. M. NACLERIO
Intranasal Beclomethasone Reduces Allergen-induced Symptoms and Superficial Mucosal Eosinophilia without Affecting Submucosal Inflammation
Am. J. Respir. Crit. Care Med.,
March 1, 1998;
157(3):
899 - 906.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Matsukura, F. Kokubu, H. Kubo, T. Tomita, H. Tokunaga, M. Kadokura, T. Yamamoto, Y. Kuroiwa, T. Ohno, H. Suzaki, et al.
Expression of RANTES by Normal Airway Epithelial Cells after Influenza Virus A Infection
Am. J. Respir. Cell Mol. Biol.,
February 1, 1998;
18(2):
255 - 264.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Ray, L. Yang, D.-H. Zhang, S. K. Ghosh, and A. Ray
Selective Up-regulation of Cytokine-induced RANTES Gene Expression in Lung Epithelial Cells by Overexpression of Ikappa BR
J. Biol. Chem.,
August 8, 1997;
272(32):
20191 - 20197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. VIGNOLA, J. BOUSQUET, P. CHANEZ, R. GAGLIARDO, A. M. MERENDINO, G. CHIAPPARA, and G. BONSIGNORE
Assessment of Airway Inflammation in Asthma
Am. J. Respir. Crit. Care Med.,
May 1, 1997;
157(5):
184 - 187.
[Full Text]
|
 |
|
Copyright © 1996 American Thoracic Society.
|
|
|